Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis (FHHNC) is a disease of renal tubular disorder. The symptoms of FHHNC generally present in children or before adolescence. Mutations of CLDN16 or CLDN19 is the main reason of this infrequent disease. Claudin-16 is encoded by CLDN-16 and CLDN19 encode the claudin-19. (1) Michelis et al. was the first person to find this disease, he reported that the feathers are excessive magnesium and calcium losses with urinary, bilateral nephrocalcinosis and progressive chronic renal failure. (11) In this essay, I will discuss the role of tight junction proteins in familial hypomagnesaemia with hypercalciuria and nephrocalcinosis (FHHNC).
Magnesium is the fourth most cation in the body, its
…show more content…
CLDN19 mice developed features of familial hypomagnesaemia with hypercalciuria and nephrocalcinosis, which contain hypomagnesemia, hypercalciuria and hypermagnesuria. Knockdown CLDN19 expression by siRNA causes the loss claudin-16 from TJs in TAL, however, knockdown CLDN16 by siRNA produce the result similar to claudin-19. Both Claudin-16 and claudin-19 shows normal barrier function after run out of TJs but it is the abnormal ion selectivity. These data indicated that heteromeric claudin-16 claudin-19 react with each other are necessary to produce TJ structure and a paracellular pathway of cation selective. Besides, some mutations of CLDN16 and CLDN19 avoid this interaction, which means the function of TAL for claudins interaction in familial hypomagnesaemia with hypercalciuria and nephrocalcinosis. …show more content…
Felix Claverie-Martin, 2015, Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis: clinical and molecular characteristics, Clinical Kidney Journal.
2. R Swaminathan, 2003, Magnesium Metabolism and its Disorders, The Clinical Biochemist Reviews
3. Rodríguez-Soriano J, Vallo A, García-Fuentes M. 1987. Hypomagnesaemia of hereditary renal origin. Pediatr Nephrol.
4. Andrea Hartsock and W.James Nelson, 2008, Adherens and Tight junctions: Structure, Function and Connections to the Actin Cytoskeleton, Biochim Biophys Acta.
5. Kiuchi-Saishin Y, Gotoh S, Furuse M, Takasuga A, Tano Y, Tsukita S. Differential expression patterns of claudins, tight junction membrane proteins, in mouse nephron segments.
6. Konrad M, Schaller A, Seelow D, et al. Mutations in the Tight-Junction Gene Claudin 19 (CLDN19) Are Associated with Renal Magnesium Wasting, Renal Failure, and Severe Ocular Involvement. American Journal of Human Genetics. 2006;79(5):949-957.
7. Hou J, Paul DL, Goodenough DA. 2005Paracellin-1 and the modulation of ion selectivity of tight junctions. J Cell Sci.
8. Hou J, Renigunta A, Konrad M, et al. 2008. Claudin-16 and claudin-19 interact and form a cation-selective tight junction complex. J Clin
performed linkage and association analyses to evaluate the roles of the neuronal constitutive (NOS1) and endothelial constitutive (NOS3) nitric oxide synthase genes and the endothelin-1 (EDN-1) gene in predisposition to chronic renal failure in African Americans [47]. The study population consisted of 361 individuals from 168 multiplex African American families and an additional 92 unrelated African Americans with type 2 diabetes mellitus-associated ESRD (singletons). Microsatellite markers NOS1B (NOS1), D7S636 (NOS3) and CPHD1-1/2 (EDN-1) were genotyped in the sample. In addition, a mutation, Glu298Asp, in exon 7 of NOS3 and a 27 bp variable number tandem repeat (VNTR) marker in intron 4 of NOS3 were evaluated. After association analyses utilizing the relative predispositional effect method and model independent linkage analyses using GeneHunter-plus and MapMaker/SIBS (exclusion analysis) software, significant evidence for association with ESRD was detected for alleles 7 and 9 of the NOS1 gene (11.9 and 34.2%, respectively, in unrelated probands of ESRD families versus 6.5 and 27.5%, respectively, in race-matched controls, both P:ll see how beautiful I
Inherited long QT syndrome is caused by genetic mutations in the genes that encode the cardiac ion channels. These genes are given names by the order in which they are discovered, for example the first would be LQT1, the next LQT2 and so on. So far over 200 genetic mutations have been discovered (3). Ion channels can be described as openings or pores in the cell membrane that allow charged particles called ions to pass in and out of the cell (4). Ion channels are classified based on how they interact with a specific ion and by their mechanism of action. Channelopathies is the name given to the group of genetic disorders that affect ion channels and the proteins that regulate them (4). A channelopathy can result
Does Notch Delta interact at new adherens junction interface formed between the two sister cells?
According to (Bennett, Rahbari-Oskoui, Chapman, Perrone, & Sheridan, 2014) ADPKD is the most common hereditary kidney disease, resulting 1 in every 400 to 1000 people; kidneys become
Marfan syndrome is a histological disorder that specifically deals with one of the four primary types of tissue known as connective tissue. Marfan syndrome is also considered an autosomal dominant disease, meaning this disorder requires only one parent or donor to carry the abnormal gene for it to be inherited in the offspring. The inheritance of the abnormal gene is the biological basis or genetic trigger that results in a mutation that occurs in the gene named fibrillin-1, or short FBN1. The respective location of gene FBN1 is on chromosome 15. Function of the FBN1 gene includes storing the blueprints for making the glycoprotein fibrillin-1, which is a component of many tissues. When produced, the fibrillin-1 protein exits the cell via transport
Some of these adapter proteins also interact with a docking protein (SNARE) on the plasma membrane and assist FL-myoVa to act as a tether for releasing cargo4-6. For example, Gran A/B directly binds to syntaxin 1a, a SNARE protein responsible for docking the granule at the plasma
Classical Calpains, especially those found in humans, are ubiquioltly expressed and are controlled through the inhibitor of Calpastain (Trinchese et al., 2008). Although the role of calcium inducing change to enable Calpastatin to bind to Calpain is unknown, it is seen that Calpain 2 is bounded by inhibitory domains of Calpastatin which are inhibiting Calpain from both sides of the active site cleft. From this it was assumed that Calpastatin not only recognizes that there are multiple lower affinity sites but, that they are only present in the calcium-bound form of the enzyme which results in the interaction between Calpain and Calpastatin to be tight, specific and calcium dependent (Hanna, Campbell, & Davies, 2008).
End Stage Renal Disease is the last stage of Chronic Kidney Disease (CKD) which is a “progressive, irreversible loss of kidney function” (Lewis et. al. 2017 pp.1075). The kidneys are the main organs of the urinary system. They have many functions but the main functions are to “regulate the volume and composition of extracellular fluid and excrete waste products from the body” and maintaining hemostasis (Lewis et. al. 2017 pp 1015). The microstructures of the kidney that are most involved with the function of the kidney are the nephrons. The nephrons are responsible for filtering the blood from toxins such as uremia, creatinine and hydrogen. Therefore, when the nephrons are compromised by uremia, the manifestations can spread systemically. The
The absorptive hypercalciuria is an inherited autosomal dominant trait disorder due to increased passive absorption of calcium and oxalate in the jejunum region.
The C-Terminal Ser/Pro-rich domain has no known function in microtubule binding as of yet. Rather, it functions as an interaction site for other molecules. This suggests that DCX is involved in signaling pathways: DCX is phosphorylated by both Cyclin-dependent kinase 5 (CDK5) and c-jun NH2-terminal kinase (JNK)7,8 at the Ser/Pro-rich domain. Phosphorylation of DCX by CDK5 controls and localizes DCX to fine perinuclear microtubules but not to microtubule bundles in proximal processes. This phosphorylation is developmentally regulated by p35, the major activating subunit for CDK58. At the growth cones, DCX is co-localized with JNK. Phosphorylation of DCX by JNK facilitates neurite outgrowth during differentiation, a process which is important in migration. Additionally, DCX interacts with JNK–interacting protein-1 (JIP-1), a scaffold protein that facilitates its phosphorylation by JNK and furthermore might provide a crosstalk with the reelin pathway7,9. A defective cortical layering phenotype is also observed in individuals with mutations in the REELIN gene. Other phosporylation proteins for DCX are PKA and MARK. Dcx/microtubule interactions are negatively controlled by PKA and MARK at the growth cones.10 Unlike the other two kinases, PKA and and MARK does not phosporylate DCX at the Ser/Pro domain, but at several other sites, with the most important one being S47. The C-terminal region of DCX regulates filamentous actin polymerization in
Mutations for KLHL3 that cause disease all involve missense mutations, resulting in a different amino acid, again noting the inability to interact with substrates (7). One mutation, for example, resulted in a cytosine to thymine nucleotide change at codon 410, changing from a serine to a leucine amino acid. This change in polarity, moving from a polar to nonpolar amino acid, disrupts regular formation of the E3 complex, not allowing for ubiquitin attachment. These missense mutations often inhibit the ability of the KLHL3 protein to form the E3 ubiquitin ligase complex, and so this prevents the normal function of identifying extraneous and damaged proteins, resulting in an excess of WNK4, due to no protein degradation as a result of the inability to tag these excess proteins. This inability to form the complex in some mutations is a result of the cluster of serine residues that were affected by the mutation, building up on the propeller domains, disrupting interactions with substrate and/or altering protein structure, though it is more common to see one or the other (6). This leads to high blood pressure, due to no control over WNK4 concentrations in the blood. It was commented on that the majority of mutations affected the ability of the KLHL3 to associate with the rest of the complex, therefore unable to
The abnormal accumulation of calcium in tissues where it should not be physiologically found happens as a result of many factors. This buildup of mineral may occur in specific tissues/ organs or widely throughout the body. While some instances of calcification may be completely harmless, there are those that may signal serious underlying disorders. These factors may be broadly categorized into two major causes, namely an elevated calcium blood level (hypercalcemia) and tissue injury, both which may be triggered by a plethora of conditions.
CCT is a highly heritable and one of the most correlated quntitive ocular trait (Ref). It is a hallmark of diseases such as keratoconus and a rsik facor for POAG in individuals with high IOP. In table 1B, we compile information on following fifteen genes and sequence variants identified through GWAS using CCT as a quantitative trait; 1. A kinase (PRKA) anchor protein 13 (AKAP13), 2. fibroblast growth factor 9 related (AVGR8/FGF9-SGCG); 3. Chondroitin sulfate synthase 1 (CHSY1); 4. Collagen type 8 alpha 2 (COL8A2); 5. CWC27 spliceosome-associated protein homolog (CWC27-ADAMTS6); 6. fibronectin type III domain containing 3B (FNDC3B); 7. forkhead box O1 (FOXO1); 8. G protein-coupled receptor 15 (GPR15); 9. heparan sulfate (glucosamine)
The plasma membrane of a cell allow some molecules into the cell while keeping other out. This is done by selecting permeability to the right ions and organic molecule
Genetic Links: Family history may also affect the likelihood of this disease, if an individual’s family earlier has any link with kidney disorders.